Viatris Low-Dose Estrogen Patch Phase 3 Data Update
Pittsburgh, USA | May 1, 2026 Viatris has announced multiple clinical data presentations for its investigational low-dose estrogen combined...
pharmacokinetics
Advertisement
RenovoRx Showcases TAMP Platform Data at ASCO 2026
Mountain View, California, USA – April 23, 2026 RenovoRx announced that a pharmacokinetic (PK) and pharmacodynamic (PD) data abstract...
Harbour BioMed Reports Phase I Success for HBM9378 Antibody
Cambridge, Massachusetts, USA / Rotterdam, Netherlands / Shanghai, China | March 22, 2026 Harbour BioMed has announced the online...
FDA Issues CRL for Pediatric Joenja in Rare Immunodeficiency
LEIDEN, Netherlands, Feb. 1, 2026 — Pharming Group announced that the U.S. Food and Drug Administration (FDA) has issued...
Sagimet Advances MASH Combination Therapy With Phase 1 PK Data
SAN MATEO, Calif., Dec. 18, 2025 — Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company focused on metabolic and fibrotic...
Advertisement
